CLEOCIN PHOSPHATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cleocin Phosphate, and what generic alternatives are available?
Cleocin Phosphate is a drug marketed by Pfizer and Pharmacia And Upjohn and is included in four NDAs.
The generic ingredient in CLEOCIN PHOSPHATE is clindamycin phosphate. There are fifty-five drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the clindamycin phosphate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cleocin Phosphate
A generic version of CLEOCIN PHOSPHATE was approved as clindamycin phosphate by ALMAJECT on July 24th, 1987.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CLEOCIN PHOSPHATE?
- What are the global sales for CLEOCIN PHOSPHATE?
- What is Average Wholesale Price for CLEOCIN PHOSPHATE?
Summary for CLEOCIN PHOSPHATE
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 4 |
| Finished Product Suppliers / Packagers: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 57 |
| Clinical Trials: | 1 |
| Patent Applications: | 2,341 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for CLEOCIN PHOSPHATE |
| What excipients (inactive ingredients) are in CLEOCIN PHOSPHATE? | CLEOCIN PHOSPHATE excipients list |
| DailyMed Link: | CLEOCIN PHOSPHATE at DailyMed |
Recent Clinical Trials for CLEOCIN PHOSPHATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| GlaxoSmithKline | Phase 1 |
| Stiefel, a GSK Company | Phase 1 |
Pharmacology for CLEOCIN PHOSPHATE
| Drug Class | Lincosamide Antibacterial |
| Physiological Effect | Decreased Sebaceous Gland Activity Neuromuscular Blockade |
US Patents and Regulatory Information for CLEOCIN PHOSPHATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pfizer | CLEOCIN PHOSPHATE | clindamycin phosphate | INJECTABLE;INJECTION | 062803-001 | Oct 16, 1987 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Pfizer | CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER | clindamycin phosphate | INJECTABLE;INJECTION | 050639-001 | Aug 30, 1989 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pfizer | CLEOCIN PHOSPHATE | clindamycin phosphate | INJECTABLE;INJECTION | 050441-001 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
